About Deepcell
The Problem Deepcell addresses a core healthcare pain point: fragmented operations, slow decision cycles, and poor visibility across teams. Organizations in this market often rely on disconnected tools, which creates delays, revenue leakage, and inconsistent customer outcomes.
The Solution Deepcell uses AI to isolate and capture cells based on morphological features, for multiple research and translational applications Healthcare Biotech Artificial Intelligence In practice, Deepcell centralizes critical workflows, automates repetitive coordination, and gives operators a real-time system of record. This reduces manual overhead and improves execution quality at scale.
Why it's growing With the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Deepcell is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Culture The team operates in a fast-paced environment focused on healthcare innovation, product velocity, and customer-centric execution. Their culture emphasizes ownership, experimentation, and measurable outcomes.
Why it Matters
Deepcell matters now because with the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Deepcell is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Funding Snapshot
- Series B • Andreessen Horowitz, $73M Series B in 2022
Hiring Roles
This company is actively hiring.
Meet the Founders
Deepcell Team
Founder & CEO